Role of Microglia in Age-Related Changes to the Nervous System

Microglia play a curious role in the nervous system. Their role is intrinsically protective and supportive, but during neurodegenerative disease, it is well established that microglia play a significant role in the initiation of neuronal death. Microglia, like neurons, show age-related changes that could potentially alter their behavior. While extreme changes to a large population of microglia cause dramatic neuronal loss in neurodegeneration, during normal aging, subtle changes not unlike those seen in the disease state could potentially contribute to a more gradual neuronal loss that could contribute to the cognitive decline seen in the aging population. This review provides illustrations of what is known about the role of microglia in neurodegeneration and makes suggestions about the role of microglia in age-related changes to the brain.

[1]  Stephen D Miller,et al.  Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis , 2003, Journal of Neuroimmunology.

[2]  R. Simone,et al.  Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems. , 2007, CNS & neurological disorders drug targets.

[3]  R. Mohney,et al.  Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia , 2000, The Journal of Neuroscience.

[4]  B. Liu,et al.  Role of Nitric Oxide in Inflammation‐Mediated Neurodegeneration , 2002, Annals of the New York Academy of Sciences.

[5]  F. Tagliavini,et al.  Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. , 1999, Neuroreport.

[6]  Douglas R. McDonald,et al.  A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation , 2003, The Journal of Neuroscience.

[7]  J. Rose,et al.  Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion , 2004, Journal of Neuroimmunology.

[8]  Jim Mintz,et al.  Brain ferritin iron may influence age- and gender-related risks of neurodegeneration , 2007, Neurobiology of Aging.

[9]  S. Frautschy,et al.  Aminopyridazines inhibit β-amyloid-induced glial activation and neuronal damage in vivo , 2004, Neurobiology of Aging.

[10]  Bernhard Schmidt,et al.  Role of microglia and host prion protein in neurotoxicity of a prion protein fragment , 1996, Nature.

[11]  Rodney W. Johnson,et al.  Neuroinflammation Associated with Aging Sensitizes the Brain to the Effects of Infection or Stress , 2008, Neuroimmunomodulation.

[12]  D. Loeffler,et al.  Effects of Enhanced Striatal Dopamine Turnover In Vivo on Glutathione Oxidation , 1994, Clinical neuropharmacology.

[13]  G. Kreutzberg.  Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[14]  A. Swaak,et al.  Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases. , 1984, The Journal of clinical investigation.

[15]  David R. Brown,et al.  Astrocytic regulation of NMDA receptor subunit composition modulates the toxicity of prion peptide PrP106–126 , 2004, Molecular and Cellular Neuroscience.

[16]  H. Yamaguchi,et al.  Microglial activation in early stages of amyloid β protein deposition , 1997, Acta Neuropathologica.

[17]  M. Gencic,et al.  Experimental studies on kinetics and functions of monuclear phagozytes of the central nervous system. , 1975, Acta neuropathologica. Supplementum.

[18]  P. Lucassen,et al.  PrP Deposition, Microglial Activation, and Neuronal Apoptosis in Murine Scrapie , 1997, Experimental Neurology.

[19]  Alun Williams,et al.  Killing of prion-damaged neurones by microglia , 2001, Neuroreport.

[20]  B. Liu,et al.  Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons , 2002, The Journal of Neuroscience.

[21]  C. Colton,et al.  Production of superoxide anions by a CNS macrophage, the microglia , 1987, FEBS letters.

[22]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[23]  S. T. Dheen,et al.  Retinoic acid inhibits expression of TNF‐α and iNOS in activated rat microglia , 2005 .

[24]  Bin Liu,et al.  Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention , 2003, Journal of Pharmacology and Experimental Therapeutics.

[25]  R. Mckeon,et al.  Characterization of cellular and neurological damage following unilateral hypoxia/ischemia , 2004, Journal of the Neurological Sciences.

[26]  P. Mcgeer,et al.  Anti‐Inflammatory Drugs in the Fight against Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.

[27]  A. Roher,et al.  Specific Domains of β-Amyloid from Alzheimer Plaque Elicit Neuron Killing in Human Microglia , 1996, The Journal of Neuroscience.

[28]  Wei Zhang,et al.  The role of microglia in paraquat-induced dopaminergic neurotoxicity. , 2005, Antioxidants & redox signaling.

[29]  Alun Williams,et al.  Prostaglandin D2 mediates neuronal damage by amyloid-β or prions which activates microglial cells , 2006, Neuropharmacology.

[30]  W. Robberecht,et al.  Microglia in amyotrophic lateral sclerosis. , 2007, Acta neurologica Belgica.

[31]  J. Chabry,et al.  Neurons and Astrocytes Respond to Prion Infection by Inducing Microglia Recruitment , 2004, The Journal of Neuroscience.

[32]  G. Landreth,et al.  Microglial Phagocytosis of Fibrillar β-Amyloid through a β1 Integrin-Dependent Mechanism , 2004, The Journal of Neuroscience.

[33]  R. Meyermann,et al.  Reactive microgIia in Creutzfeldt‐Jakob disease , 1995, Neuropathology and applied neurobiology.

[34]  V. Perry,et al.  Characterization of the microglial response in murine scrapie , 1994, Neuropathology and applied neurobiology.

[35]  KenjiSunagawa,et al.  Overexpression of Mitochondrial Transcription Factor A Ameliorates Mitochondrial Deficiencies and Cardiac Failure After Myocardial Infarction , 2005 .

[36]  D. Schubert,et al.  The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. , 1992, Biochemical and biophysical research communications.

[37]  E. Perry,et al.  Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial , 2003, Pharmacology Biochemistry and Behavior.

[38]  H. Nakanishi,et al.  Microglia-aging: Roles of microglial lysosome- and mitochondria-derived reactive oxygen species in brain aging , 2009, Behavioural Brain Research.

[39]  W. Streit,et al.  Characterization of microglial reaction after middle cerebral artery occlusion in rat brain , 1993, The Journal of comparative neurology.

[40]  M. Sawada,et al.  Effects of Aging on Neuroprotective and Neurotoxic Properties of Microglia in Neurodegenerative Diseases , 2008, Neurodegenerative Diseases.

[41]  S. Hirai,et al.  Activated microglia cause superoxide-mediated release of iron from ferritin , 1995, Neuroscience Letters.

[42]  D. Sparks,et al.  Dystrophic microglia in the aging human brain , 2004, Glia.

[43]  B. McEwen,et al.  Microglia derived from aging mice exhibit an altered inflammatory profile , 2007, Glia.

[44]  Bin Liu,et al.  Microglia enhance β‐amyloid peptide‐induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species , 2002 .

[45]  D W Dickson,et al.  Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. , 1993, Journal of immunology.

[46]  H. Yamaguchi,et al.  Microglial activation in early stages of amyloid beta protein deposition. , 1997, Acta neuropathologica.

[47]  Kuhlmann,et al.  Identification of glial cell proliferation in early multiple sclerosis lesions , 1998, Neuropathology and applied neurobiology.

[48]  T. Marunouchi,et al.  Production of tumor necrosis factor-alpha by microglia and astrocytes in culture , 1989, Brain Research.

[49]  P. Mcgeer,et al.  Glial reactions in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[50]  David R. Brown,et al.  Microglia and prion disease , 2001, Microscopy research and technique.

[51]  S. Goodman,et al.  Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer’s Disease: A Systematic Review , 2004, Neuroepidemiology.

[52]  R B Banati,et al.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.

[53]  Received July,et al.  Role of Microglia in Age-Related Changes to the Nervous System , 2009 .

[54]  N. Hamasaki,et al.  Architectural Role of Mitochondrial Transcription Factor A in Maintenance of Human Mitochondrial DNA , 2004, Molecular and Cellular Biology.

[55]  D. Ferrari,et al.  Activation of microglial cells by beta-amyloid protein and interferon-gamma. , 1995, Nature.

[56]  Y. Ichimori,et al.  β-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity , 1996, Brain Research.

[57]  A. Giese,et al.  Role of Microglia in Neuronal Cell Death in Prion Disease , 1998, Brain pathology.

[58]  M. Graeber,et al.  Functional plasticity of microglia: A review , 1988, Glia.

[59]  David R. Brown,et al.  A Model for the Mechanism of Astrogliosis in Prion Disease , 2000, Molecular and Cellular Neuroscience.

[60]  S. Koizumi,et al.  Activation of p38 mitogen‐activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury , 2004, Glia.

[61]  David R. Brown.  Prion protein expression modulates neuronal copper content , 2003, Journal of neurochemistry.

[62]  Wenyu Bu,et al.  Tenascin-R Plays a Role in Neuroprotection via Its Distinct Domains That Coordinate to Modulate the Microglia Function* , 2005, Journal of Biological Chemistry.

[63]  Belinda Wilson,et al.  Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[64]  V. Perry,et al.  Turnover of resident microglia in the normal adult mouse brain , 1992, Neuroscience.

[65]  Bin Liu,et al.  NADPH Oxidase Mediates Lipopolysaccharide-induced Neurotoxicity and Proinflammatory Gene Expression in Activated Microglia* , 2004, Journal of Biological Chemistry.

[66]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[67]  H. Kretzschmar,et al.  Increase of intracellular free Ca2+ in microglia activated by prion protein fragment , 1997, Glia.

[68]  A. Contestabile,et al.  Microglial cells protect cerebellar granule neurons from apoptosis: Evidence for reciprocal signaling , 2001, Glia.

[69]  D. Sparks,et al.  Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity , 2008, Glia.

[70]  M. Citron,et al.  Anti-Inflammatory Drug Therapy Alters β-Amyloid Processing and Deposition in an Animal Model of Alzheimer's Disease , 2003, The Journal of Neuroscience.

[71]  Deanna L. Taylor,et al.  Microglia release activators of neuronal proliferation mediated by activation of mitogen‐activated protein kinase, phosphatidylinositol‐3‐kinase/Akt and delta–Notch signalling cascades , 2004, Journal of neurochemistry.

[72]  S. Aust,et al.  Ferritin and superoxide-dependent lipid peroxidation. , 1985, The Journal of biological chemistry.

[73]  T. Bates,et al.  Activation of murine microglial cell lines by lipopolysaccharide and interferon‐γ causes NO‐mediated decreases in mitochondrial and cellular function , 2001, The European journal of neuroscience.

[74]  W. Streit,et al.  Reactive microgliosis , 1999, Progress in Neurobiology.

[75]  L. Lue,et al.  Microglial chemotaxis, activation, and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's disease , 2001, Neurochemistry International.

[76]  H. Nakanishi,et al.  Reverse of Age-Dependent Memory Impairment and Mitochondrial DNA Damage in Microglia by an Overexpression of Human Mitochondrial Transcription Factor A in Mice , 2008, The Journal of Neuroscience.

[77]  M. Gurney,et al.  Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS , 1998 .

[78]  J. Rose,et al.  Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage , 2004, Journal of Neuroimmunology.

[79]  P. Sharma,et al.  Release of iron from ferritin by metabolites of benzene and superoxide radical generating agents. , 2001, Toxicology.

[80]  B. Liu,et al.  Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. , 2003, Environmental health perspectives.

[81]  S. Hirai,et al.  Detection of Superoxide Production by Activated Microglia Using a Sensitive and Specific Chemiluminescence Assay and Microglia‐Mediated PC12h Cell Death , 1994, Journal of neurochemistry.

[82]  M. Graeber,et al.  The microglial cytoskeleton: vimentin is localized within activated cellsin situ , 1988, Journal of neurocytology.

[83]  D. Holtzman,et al.  Microglia Mediate the Clearance of Soluble Aβ through Fluid Phase Macropinocytosis , 2009, The Journal of Neuroscience.

[84]  H. Kretzschmar,et al.  Microglial expression of the prion protein , 1998, Neuroreport.

[85]  Stephen F. Barnes.  The Aging Human Brain , 2010 .

[86]  A. Floden,et al.  β-Amyloid Stimulates Murine Postnatal and Adult Microglia Cultures in a Unique Manner , 2006, The Journal of Neuroscience.

[87]  Y. Matsumoto,et al.  Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system , 1992, Journal of Neuroimmunology.

[88]  E. Richfield,et al.  Age‐related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype , 2003, The European journal of neuroscience.

[89]  J. Connor,et al.  Iron, Transferrin, and Ferritin in the Rat Brain During Development and Aging , 1994, Journal of neurochemistry.

[90]  David R. Brown.  Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence. , 2006, Folia neuropathologica.

[91]  E. Ling,et al.  Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. , 2005, Glia.

[92]  R. Veerhuis,et al.  Microglia kill amyloid-&bgr;1-42 damaged neurons by a CD14-dependent process , 2004, NeuroReport.